BNP has been accepted as a valuable marker for the prediction of left ventricular dysfunction in the last decade, and AMI patients are demonstrated to have a significantly higher BNP level than patients with non‐cardiac chest pain or unstable angina 33. This evidence concerns the gene NPPB and angina pectoris.